R Squared LTD Aclaris Therapeutics, Inc. Transaction History

R Squared LTD

$214 Billion
Q4 2025

A detailed history of R Squared LTD transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, R Squared LTD holds 12,408 shares of ACRS stock, worth $31,268. This represents 0.02% of its overall portfolio holdings.

Number of Shares

12,408

Holding current value

$31,268

% of portfolio

0.02%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2025 Jan 29, 2026	BUY	$1.81 - $2.56 $22,458 - $31,764	12,408 New	12,408 $37.3 Million
Q4 2024 Jan 22, 2025	BUY	$1.15 - $4.59 $701 - $2,799	610 New	610 $1.51 Million

Others Institutions Holding ACRS

# of Institutions

108

Shares Held

82M

Call Options Held

Put Options Held

Bml Capital Management, LLC Zionsville, IN

14.3M
Shares

$35.9 Million
24.79% of portfolio
Vivo Capital, LLC Palo Alto, CA

8.89M
Shares

$22.4 Million
2.68% of portfolio
Vanguard Group Inc Valley Forge, PA

6.5M
Shares

$16.4 Million
0.0% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

5.28M
Shares

$13.3 Million
0.02% of portfolio
Rock Springs Capital Management LP Baltimore, MD

4.61M
Shares

$11.6 Million
0.59% of portfolio

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $168M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of R Squared LTD, based on Form 13F filings with the SEC.

News

Stay updated on R Squared LTD with notifications on news.

Account